Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Nat Commun ; 12(1): 6187, 2021 10 26.
Article in English | MEDLINE | ID: mdl-34702855

ABSTRACT

Attention-deficit hyperactivity disorder (ADHD) is a common childhood-onset psychiatric disorder characterized by inattention, impulsivity and hyperactivity. ADHD exhibits substantial heritability, with rare monogenic variants contributing to its pathogenesis. Here we demonstrate familial ADHD caused by a missense mutation in CDH2, which encodes the adhesion protein N-cadherin, known to play a significant role in synaptogenesis; the mutation affects maturation of the protein. In line with the human phenotype, CRISPR/Cas9-mutated knock-in mice harboring the human mutation in the mouse ortholog recapitulated core behavioral features of hyperactivity. Symptoms were modified by methylphenidate, the most commonly prescribed therapeutic for ADHD. The mutated mice exhibited impaired presynaptic vesicle clustering, attenuated evoked transmitter release and decreased spontaneous release. Specific downstream molecular pathways were affected in both the ventral midbrain and prefrontal cortex, with reduced tyrosine hydroxylase expression and dopamine levels. We thus delineate roles for CDH2-related pathways in the pathophysiology of ADHD.


Subject(s)
Antigens, CD/genetics , Antigens, CD/metabolism , Attention Deficit Disorder with Hyperactivity/genetics , Attention Deficit Disorder with Hyperactivity/physiopathology , Cadherins/genetics , Cadherins/metabolism , Animals , Antigens, CD/chemistry , Attention Deficit Disorder with Hyperactivity/drug therapy , Attention Deficit Disorder with Hyperactivity/metabolism , Cadherins/chemistry , Child , Dopamine/metabolism , Gene Expression Profiling , Homozygote , Humans , Locomotion/drug effects , Male , Methylphenidate/therapeutic use , Mice , Mutation , Neurons/metabolism , Prefrontal Cortex/metabolism , Protein Conformation , Siblings , Synaptic Transmission/drug effects , Synaptic Vesicles/metabolism , Tyrosine 3-Monooxygenase/metabolism
2.
Mol Psychiatry ; 23(6): 1432-1445, 2018 06.
Article in English | MEDLINE | ID: mdl-29257131

ABSTRACT

Stress-related psychopathology is highly prevalent among elderly individuals and is associated with detrimental effects on mood, appetite and cognition. Conversely, under certain circumstances repeated mild-to-moderate stressors have been shown to enhance cognitive performance in rodents and exert stress-inoculating effects in humans. As most stress-related favorable outcomes have been reported in adolescence and young-adulthood, this apparent disparity could result from fundamental differences in how aging organisms respond to stress. Furthermore, given prominent age-related alterations in sex hormones, the effect of chronic stress in aging females remains a highly relevant yet little studied issue. In the present study, female C57BL/6 mice aged 3 (young-adult) and 20-23 (old) months were subjected to 8 weeks of chronic unpredictable stress (CUS). Behavioral outcomes were measured during the last 3 weeks of the CUS protocol, followed by brain dissection for histological and molecular end points. We found that in young-adult female mice, CUS resulted in decreased anxiety-like behavior and enhanced cognitive performance, whereas in old female mice it led to weight loss, dysregulated locomotion and memory impairment. These phenotypes were paralleled by differential changes in the expression of hypothalamic insulin and melanocortin-4 receptors and were consistent with an age-dependent reduction in the dynamic range of stress-related changes in the hippocampal transcriptome. Supported by an integrated microRNA (miRNA)-mRNA expression analysis, the present study proposes that, when confronted with ongoing stress, neuroprotective mechanisms involving the upregulation of neurogenesis, Wnt signaling and miR-375 can be harnessed more effectively during young-adulthood. Conversely, we suggest that aging alters the pattern of immune activation elicited by stress. Ultimately, interventions that modulate these processes could reduce the burden of stress-related psychopathology in late life.


Subject(s)
Anxiety/metabolism , Cognition/physiology , Stress, Psychological/metabolism , Age Factors , Animals , Behavior, Animal , Brain/metabolism , Female , Hippocampus/metabolism , Mice , Mice, Inbred C57BL , Neurobiology , Neurogenesis/physiology
3.
Mol Psychiatry ; 22(6): 884-899, 2017 06.
Article in English | MEDLINE | ID: mdl-27021817

ABSTRACT

Many psychiatric disorders are highly heritable and may represent the clinical outcome of early aberrations in the formation of neural networks. The placement of brain connectivity as an 'intermediate phenotype' renders it an attractive target for exploring its interaction with genomics and behavior. Given the complexity of genetic make up and phenotypic heterogeneity in humans, translational studies are indicated. Recently, we demonstrated that a mouse model with heterozygous knockout of the key neurodevelopmental gene Ahi1 displays a consistent stress-resilient phenotype. Extending these data, the current research describes our multi-faceted effort to link early variations in Ahi1 expression with long-term consequences for functional brain networks and cognitive-emotional phenotypes. By combining behavioral paradigms with graph-based analysis of whole-brain functional networks, and then cross-validating the data with robust neuroinformatic data sets, our research suggests that physiological variation in gene expression during neurodevelopment is eventually translated into a continuum of global network metrics that serve as intermediate phenotypes. Within this framework, we suggest that organization of functional brain networks may result, in part, from an adaptive trade-off between efficiency and resilience, ultimately culminating in a phenotypic diversity that encompasses dimensions such as emotional regulation and cognitive function.


Subject(s)
Nerve Net/physiology , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins/metabolism , Adaptor Proteins, Vesicular Transport , Animals , Brain/physiopathology , Brain Mapping , Cognition/physiology , Emotions/physiology , Female , Gene Expression , Male , Mice , Mice, Inbred C57BL , Mice, Knockout
5.
Mol Psychiatry ; 19(2): 243-52, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24042478

ABSTRACT

The Abelson helper integration site 1 (AHI1) gene has a pivotal role in brain development. Studies by our group and others have demonstrated association of AHI1 with schizophrenia and autism. To elucidate the mechanism whereby alteration in AHI1 expression may be implicated in the pathogenesis of neuropsychiatric disorders, we studied Ahi1 heterozygous knockout (Ahi1(+/-)) mice. Although their performance was not different from wild-type mice on tests that model classical schizophrenia-related endophenotypes, Ahi1(+/-) mice displayed an anxiolytic-like phenotype across different converging modalities. Using behavioral paradigms that involve exposure to environmental and social stress, significantly decreased anxiety was evident in the open field, elevated plus maze and dark-light box, as well as during social interaction in pairs. Assessment of core temperature and corticosterone secretion revealed a significantly blunted response of the autonomic nervous system and the hypothalamic-pituitary-adrenal axis in Ahi1(+/-) mice exposed to environmental and visceral stress. However, response to centrally acting anxiogenic compounds was intact. On resting-state functional MRI, connectivity of the amygdala with other brain regions involved in processing of anxiogenic stimuli and inhibitory avoidance learning, such as the lateral entorhinal cortex, ventral hippocampus and ventral tegmental area, was significantly reduced in the mutant mice. Taken together, our data link Ahi1 under-expression with a defect in the process of threat detection. Alternatively, the results could be interpreted as representing an anxiety-related endophenotype, possibly granting the Ahi1(+/-) mouse relative resilience to various types of stress. The current knockout model highlights the contribution of translational approaches to understanding the genetic basis of emotional regulation and its associated neurocircuitry, with possible relevance to neuropsychiatric disorders.


Subject(s)
Anxiety/physiopathology , Neurons/physiology , Proto-Oncogene Proteins/metabolism , Stress, Psychological/physiopathology , Adaptor Proteins, Vesicular Transport , Animals , Anxiety/chemically induced , Anxiety/etiology , Body Temperature , Brain/growth & development , Brain/pathology , Brain/physiopathology , Corticosterone/metabolism , Environment , Hypothalamo-Hypophyseal System/physiopathology , Mice , Mice, Inbred C57BL , Mice, Knockout , Motor Activity/physiology , Pituitary-Adrenal System/physiopathology , Proto-Oncogene Proteins/genetics , Rest/physiology , Schizophrenia/physiopathology , Sensory Gating/physiology , Social Behavior , Stress, Psychological/complications
6.
J Pharmacol Exp Ther ; 337(2): 494-502, 2011 May.
Article in English | MEDLINE | ID: mdl-21317357

ABSTRACT

Although triiodothyronine (T3) is widely used clinically, preclinical support for its antidepressant-like effects is limited, and the mechanisms are unknown. We evaluated 1) the antidepressant-like effects of T3 in the novelty suppressed feeding test (NSFT), tail suspension test (TST), and forced swim test (FST), 2) the role of presynaptic 5-HT(1A) receptors in the antidepressant-like mechanism of T3 by the hypothermic response to the 5-HT(1A) receptor agonist, 8-hydroxy-N,N-dipropyl-2-aminotetralin (8-OH-DPAT), 3) the thyroid hormone receptor type mediating the antidepressant-like effects by concurrent administration of the specific thyroid hormone α receptor (TRα) antagonist, dronedarone, and 4) the presence of these effects in both genders. Male and female BALB/c mice were administered 1) T3 (20, 50, 200, or 500 µg/kg per day) or vehicle or 2) T3 (50 µg/kg per day), dronedarone (100 µM/day), or the combination intraperitoneally for 21 days and then underwent a behavioral test battery. The NSFT showed a shortened latency to feed in males at the two lower T3 doses. The TST and FST showed decreased immobility in male mice at T3 doses >20 µg/kg per day and in females at all T3 doses. Concurrent dronedarone prevented T3 effects in males on the NSFT and in the TST and FST in both genders. Attenuation of 8-OH-DPAT-induced hypothermia was observed in males only and may be reduced by concurrent dronedarone. These findings support an antidepressant-like effect of T3. Attenuation of 8-OH-DPAT-induced hypothermia in males only suggests the need to evaluate a possible gender disparity in the role of presynaptic 5-HT(1A) receptors in T3 antidepressant mechanisms. Blockade by dronedarone of the antidepressant-like effects of T3 suggests that these effects are TRα receptor-mediated.


Subject(s)
Antidepressive Agents/pharmacology , Receptor, Serotonin, 5-HT1A/drug effects , Thyroid Hormone Receptors alpha/drug effects , Triiodothyronine/pharmacology , 8-Hydroxy-2-(di-n-propylamino)tetralin/pharmacology , Amiodarone/analogs & derivatives , Amiodarone/pharmacology , Animals , Body Weight/drug effects , Dose-Response Relationship, Drug , Dronedarone , Drug Evaluation, Preclinical , Environment , Feeding Behavior/drug effects , Female , Hindlimb Suspension/psychology , Hypothermia/chemically induced , Male , Mice , Mice, Inbred BALB C , Receptors, Presynaptic , Serotonin Antagonists/pharmacology , Serotonin Receptor Agonists/pharmacology , Sex Characteristics , Swimming/psychology
SELECTION OF CITATIONS
SEARCH DETAIL
...